Zambian Government announces results of trials of HIV/AIDS herbal remedies

NewsGuard 100/100 Score

The Zambian government on Friday announced that clinical trials of three herbal HIV/AIDS remedies found that the treatments are not effective cures for the disease, AFP/Yahoo! News reports.

According to Health Minister Angela Cifire, the six-month trial conducted among 26 participants found that the herbal remedies might be an effective method of prolonging the lives of HIV-positive people but were not effective cures.

She added that none of the participants died during the trials and that no side effects were recorded.

According to Cifire, some manufacturers of the herbal remedies said that they would be able to cure HIV/AIDS in three months, but researchers decided to conduct a longer trial.

Some manufacturers also have said that the remedies would prove an effective cure if the trials are continued with a larger number of participants.

The government spent about $340,000 on the trials, according to AFP/Yahoo! News (AFP/Yahoo! News, 2/23).

Zambian officials in October 2005 announced the launch of similar trials of three herbal HIV/AIDS remedies. The three-month trials, conducted among 25 HIV-positive people, conformed to World Health Organization guidelines.

Patrick Chikusu, principal investigator of clinical trials of traditional herbal remedies, said the three remedies studied were: the Sondashi formulation, made by former Works and Supply Minister Ludwig Sondashi; the Mailacin formulation, made by a school teacher; and the Mayeyanin formulation.

Chikusu said that each of the formulations is safe to use and that each has shown evidence of reducing HIV viral loads and increasing the number of CD4+ T cells (Kaiser Daily HIV/AIDS Report, 10/21/05).

Kaiser Health NewsThis article was reprinted from with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New drug candidates show promise to reverse HIV immune evasion